Effigenta Cream
- Regular price
-
Rs.122.00 - Regular price
-
- Sale price
-
Rs.122.00
Shipping calculated at checkout.
Couldn't load pickup availability
KEY INGREDIENTS
Effigenta containing Betamethasone Dipropionate 0.5% w/w and Gentamicin 0.1% w/w
DESCRIPTION
Effigenta cream is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies and rashes).
Betamethasone is in a class of medications called corticosteroids. It is a strong corticosteroid. It works by activating natural substances in the skin to reduce swelling, redness, and itching.
Gentamicin, an aminoglycoside antibiotic that works by stopping the growth of bacteria.
INDICATIONS/USES
Effigenta cream or ointment is indicated for the relief of the inflammatory manifestations of corticosteroid responsive dermatoses when complicated by secondary infection, caused by organisms susceptible to gentamicin or when the possibility of such infections is suspected. Such disorders include: psoriasis, contact dermatitis (dermatitis venenata), atopic dermatitis (infantile eczema, allergic dermatitis), Neurodermatitis (lichen simplex chronicus), lichen planus, eczema (including nummular eczema, hand eczema, eczematous dermatitis), Intertrigo, seborrheic dermatitis, Exfoliative dermatitis, solar dermatitis, stasis dermatitis, and anogenital and senile pruritus.
PREGNANCY AND BREASTFEEDING
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine.
PRECAUTIONS
Duration of therapy varies depending upon the extent and location of disease and patient response. However, if clinical improvement is not achieved by three to four weeks, diagnosis should be reviewed.
Effigenta containing Betamethasone Dipropionate 0.5% w/w and Gentamicin 0.1% w/w
DESCRIPTION
Effigenta cream is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies and rashes).
Betamethasone is in a class of medications called corticosteroids. It is a strong corticosteroid. It works by activating natural substances in the skin to reduce swelling, redness, and itching.
Gentamicin, an aminoglycoside antibiotic that works by stopping the growth of bacteria.
INDICATIONS/USES
Effigenta cream or ointment is indicated for the relief of the inflammatory manifestations of corticosteroid responsive dermatoses when complicated by secondary infection, caused by organisms susceptible to gentamicin or when the possibility of such infections is suspected. Such disorders include: psoriasis, contact dermatitis (dermatitis venenata), atopic dermatitis (infantile eczema, allergic dermatitis), Neurodermatitis (lichen simplex chronicus), lichen planus, eczema (including nummular eczema, hand eczema, eczematous dermatitis), Intertrigo, seborrheic dermatitis, Exfoliative dermatitis, solar dermatitis, stasis dermatitis, and anogenital and senile pruritus.
PREGNANCY AND BREASTFEEDING
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine.
PRECAUTIONS
- Long-term continuous topical therapy with EFFIGENTA should be avoided.
- Due to the content of corticosteroid, EFFIGENTA should be used with care near the eyes. Avoid getting EFFIGENTA into the eyes.
- Due to the content of corticosteroid having immunosuppressant effect, EFFIGENTA may be associated with increased susceptibility to infection, aggravation of existing infection, and activation of latent infection. It is advised to switch to systemic treatment if infection cannot be controlled with topical treatment.
- Due to the content of betamethasone Dipropionate, prolonged topical use of EFFIGENTA may cause skin atrophy.
- Instruct patients not to smoke or go near naked flames - risk of severe burns. Fabric (clothing, bedding, dressings etc.) that has been in contact with this product burns more easily and is a serious fire hazard.
- A thin film of Effigenta cream or ointment should be applied to cover completely the affected area twice daily, in the morning and at night.
- Frequency of application should be determined by the physician according to the severity of the condition.
- For some patients, adequate maintenance therapy may be achieved with less frequent application.
Duration of therapy varies depending upon the extent and location of disease and patient response. However, if clinical improvement is not achieved by three to four weeks, diagnosis should be reviewed.
